Key result
Breast adipose tissue attenuation detects metabolic syndrome with 90% sensitivity and inversely tracks cardiometabolic risk factors.
Why the study?
Certain adipose tissue depots infer higher cardiometabolic risk than BMI, but breast adipose tissue attenuation as an imaging biomarker was not assessed.
Does breast adipose tissue attenuation on CT scan correlate with cardiometabolic risk factors in women?
Cross-Sectional (n=151)
Does breast adipose tissue attenuation on CT scan correlate with cardiometabolic risk factors in women?
Breast adipose tissue attenuation on non-contrast CT is associated with cardiometabolic risk markers and may serve as an opportunistic imaging biomarker.
May flag cardiometabolic risk on routine CT; leaves open validation before clinical or research use.
Background Certain adipose tissue depots infer higher cardiometabolic risk than body mass index (BMI). Purpose To assess breast adipose tissue (BrAT) attenuation as a novel imaging biomarker for cardiometabolic risk. Material and Methods We studied 151 women (mean age = 56 ± 1 years) across the weight spectrum. BrAT attenuation, abdominal adipose tissue cross-sectional areas (CSA), and attenuation were quantified using non-contrast computed tomography (CT) scans. Cardiometabolic risk factors were assessed from medical records. Results BrAT attenuation was lower in obese women compared to lean women. BrAT attenuation was inversely associated with BMI, waist circumference, abdominal fat CSA, fasting glucose, and triglycerides ( P ≤ 0.02), and positively associated with abdominal adipose tissue attenuation ( P < 0.001). BrAT attenuation had a sensitivity of 90% but a specificity of only 35% in detecting the metabolic syndrome (area under the curve = 0.63). Conclusion BrAT attenuation is associated with cardiometabolic risk markers and could serve as an imaging biomarker for opportunistic risk assessment in patients undergoing CT examination of the chest.
No takes yet. Share an insight, caveat, or question.
Bunnell et al. (2022) conducted a cross-sectional in Cardiometabolic risk (n=151). Breast adipose tissue (BrAT) attenuation was evaluated on Detection of the metabolic syndrome (AUC 0.63). Breast adipose tissue attenuation detected metabolic syndrome with 90% sensitivity and 35% specificity (AUC = 0.63) and was inversely associated with cardiometabolic risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: